Cisplatin plus etoposide chemotherapy followed by thoracic irradiation and paclitaxel plus cisplatin consolidation therapy for patients with limited stage small cell lung carcinomaKAKOLYRIS, S; AGELIDOU, A; GEROYIANNI, A et al.Lung cancer. 2006, Vol 53, Num 1, pp 59-65, issn 0169-5002, 7 p.Article

FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIR (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC) : a multicentre randomised phase iii trial from the Hellenic Oncology Research Group (HORG)SOUGLAKOS, J; ANDROULAKIS, N; KALYKAKI, A et al.British journal of cancer. 2006, Vol 94, Num 6, pp 798-805, issn 0007-0920, 8 p.Article

Vinorelbine and cisplatin combination in pretreated patients with advanced non-small cell lung cancer pretreated with a taxane-based regimen : A multicenter phase II studyMAKRANTONAKIS, P; ZIOTOPOULOS, P; GEORGOULIAS, V et al.Lung cancer. 2006, Vol 53, Num 1, pp 85-90, issn 0169-5002, 6 p.Article

Combination of irinotecan (CPT-11) plus 5-fluorouracil and leucovorin (FOLFIRI regimen) as first line treatment for elderly patients with metastatic colorectal cancer : A phase II trialSOUGLAKOS, J; PALLIS, A; KAKOLYRIS, S et al.Oncology. 2005, Vol 69, Num 5, pp 384-390, issn 0030-2414, 7 p.Article

A dose-finding study of irinotecan (CPT-11) plus a four-day continuous 5-fluorouracil infusion in advanced colorectal cancerKAKOLYRIS, S; SOUGLAKOS, J; GEORGOULIAS, V et al.Oncology. 2001, Vol 60, Num 3, pp 207-213, issn 0030-2414Article

Successful conservative treatment of neutropenic enterocolitis complicating taxane-based chemotherapy : A report of five casesKOUROUSSIS, C; SAMONIS, G; ANDROULAKIS, N et al.American journal of clinical oncology. 2000, Vol 23, Num 3, pp 309-313, issn 0277-3732Article

A dose-escalation study of pegylated liposomal doxorubicin and oxaliplatin in patients with advanced solid tumorsKOTSAKIS, A; KOUROUSSIS, Ch; MAVROUDIS, D et al.Oncology. 2006, Vol 71, Num 3-4, pp 190-196, issn 0030-2414, 7 p.Article

A dose-escalation and pharmacokinetic study of gemcitabine and oxaliplatin in patients with advanced solid tumorsMAVROUDIS, D; PAPPAS, P; SAMONIS, G et al.Annals of oncology. 2003, Vol 14, Num 2, pp 304-312, issn 0923-7534, 9 p.Article

Irinotecan (CPT-11) in combination with infusional 5-fluorouracil and leucovorin (de Gramont regimen) as first-line treatment in patients with advanced colorectal cancer: A multicenter phase II studyVAMVAKAS, L; KAKOLYRIS, S; GEORGOULIAS, V et al.American journal of clinical oncology. 2002, Vol 25, Num 1, pp 65-70, issn 0277-3732Article

Oxaliplatin in combination with infusional 5-fluorouracil and leucovorin every 2 weeks as first-line treatment in patients with advanced colorectal cancer : A phase II studyKOUROUSSIS, Ch; SOUGLAKOS, J; GEORGOULIAS, V et al.Oncology. 2001, Vol 61, Num 1, pp 36-41, issn 0030-2414Article

A phase I clinical trial of topotecan given every 2 weeks in patients with refractory solid tumorsKAKOLYRIS, S; KOUROUSSIS, Ch; SOUGLAKOS, J et al.Oncology. 2001, Vol 61, Num 4, pp 265-270, issn 0030-2414Article

First-line chemotherapy with docetaxel for unresectable or metastatic carcinoma of the biliary tract. A multicentre phase II studyPAPAKOSTAS, P; KOUROUSSIS, Ch; ANDROULAKIS, N et al.European journal of cancer (1990). 2001, Vol 37, Num 15, pp 1833-1838, issn 0959-8049Article

Docetaxel and granulocyte colony-stimulating factor in patients with advanced non-small-cell lung cancer previously treated with platinum-based chemotherapy : a multicenter phase II trialALEXOPOULOS, K; KOUROUSSIS, C; GEORGOULIAS, V et al.Cancer chemotherapy and pharmacology. 1999, Vol 43, Num 3, pp 257-262, issn 0344-5704Article

First-line treatment of metastatic breast cancer with mitoxantrone, vinorelbine, and carboplatinKAKOLYRIS, S; KOUROUSIS, C; KOUKOURAKIS, M et al.American journal of clinical oncology. 1999, Vol 22, Num 6, pp 568-572, issn 0277-3732Article

Docetaxel (taxotere) and vinorelbine in the treatment of non-small cell lung cancerGEORGOULIAS, V; KOUROUSIS, C; HALKIADAKIS, G et al.Seminars in oncology. 1997, Vol 24, Num 4, pp S14.9-S14.14, issn 0093-7754, SUP14Article

Clinical relevance of circulating CK-19mRNA-positive tumour cells before front-line treatment in patients with metastatic breast cancerANDROULAKIS, N; AGELAKI, S; PERRAKI, M et al.British journal of cancer. 2012, Vol 106, Num 12, pp 1917-1925, issn 0007-0920, 9 p.Article

A dose escalation and pharmacokinetic study of biweekly pegylated liposomal doxorubicin, paclitaxel and gemcitabine in patients with advanced solid tumoursBOZIONELOU, V; VAMVAKAS, L; GEORGOULIAS, V et al.British journal of cancer. 2007, Vol 97, Num 1, pp 43-49, issn 0007-0920, 7 p.Article

A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancerSTATHOPOULOS, G. P; SYRIGOS, K; ANDROULAKIS, N et al.British journal of cancer. 2006, Vol 95, Num 5, pp 587-592, issn 0007-0920, 6 p.Article

Sequential gemcitabine and cisplatin followed by docetaxel as first-line treatment of advanced urothelial carcinoma : a multicenter phase II study of the Hellenic Oncology Research GroupBOUKOVINAS, I; ANDROULAKIS, N; MAVROUDIS, D et al.Annals of oncology. 2006, Vol 17, Num 11, pp 1687-1692, issn 0923-7534, 6 p.Article

ZD1839, a novel, oral epidermal growth factor receptor-tyrosine kinase inhibitor, as salvage treatment in patients with advanced non-small cell lung cancer. Experience from a single center participating in a compassionate use programPALLIS, A. G; MAVROUDIS, D; ANDROULAKIS, N et al.Lung cancer. 2003, Vol 40, Num 3, pp 301-307, issn 0169-5002, 7 p.Article

Phase I study of Paclitaxel (Taxol) and pegylated liposomal doxorubicin (Caelyx) administered every 2 weeks in patients with advanced solid tumorsMAVROUDIS, D; KOUROUSSIS, Ch; KAKOLYRIS, S et al.Oncology. 2002, Vol 62, Num 3, pp 216-222, issn 0030-2414Article

Docetaxel in combination with gemcitabine plus rhG-CSF support as second-line treatment in non-small cell lung cancer. A multicenter phase II studyKAKOLYRIS, S; PAPADAKIS, E; AGELAKI, S et al.Lung cancer. 2001, Vol 32, Num 2, pp 179-187, issn 0169-5002Article

Docetaxel in combination with carboplatin for the treatment of advanced non-small cell lung carcinoma : a multicentre phase I studyGIANNAKAKIS, T; ZIRAS, N; VLACHONIKOLIS, J et al.European journal of cancer (1990). 2000, Vol 36, Num 6, pp 742-747, issn 0959-8049Article

First-line treatment of advanced non-small-cell lung cancer with docetaxel and cisplatin : A multicenter phase II studyGEORGOULIAS, V; ANDROULAKIS, N; HERAS, P et al.Annals of oncology. 1998, Vol 9, Num 3, pp 331-334, issn 0923-7534Article

Docetaxel (taxotere) and gemcitabine in the treatment of non-small cell lung cancer : Preliminary resultsGEORGOULIAS, V; KOUROUSIS, C; KOTSAKIS, T et al.Seminars in oncology. 1997, Vol 24, Num 4, pp S14.22-S14.25, issn 0093-7754, SUP14Article